Clinical Trial

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
The study is to assess the safety, efficacy and pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-05.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-26
Trial Details
NCT Number NCT06449027
Lead Sponsor Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions Breast Cancer Subjects
Enrollment 211 participants
Start Date 2024-08-21
Primary Completion 2025-11 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-10-01